Literature DB >> 7492320

Effects of aging on the synthesis of antithrombin-binding sites on heparin chains and heparan sulphate chains in the rat.

A A Horner1.   

Abstract

[35S]Heparin proteoglycans were isolated from the skins and peritoneal mast cells of male rats aged 2 to 22 months. Their [35S]heparin chains were separated on antithrombin-agarose into fractions with high and low affinities for antithrombin. In skin, the proportion of 35S-labelled high-affinity heparin chains declined from 23% at 2 months to 8% at 12 months and did not change significantly between 12 and 22 months. In peritoneal mast cells, the proportion of 35S-labelled high-affinity heparin chains increased from 14% at 2 months to 21% at 4 months and then did not vary significantly until 15 months of age. By 21 months a consistent and significant decline to 8% occurred. The structures of high-affinity heparin proteoglycans did not change with age. Their decreased proportions, without change in their structure, may indicate that they are produced by a unique subset of mast cells, the proportion of which declines with age. [35S]heparan sulphate chains were isolated from skins and brains of rats in the same age range and fractionated on antithrombin-agarose. There were no significant variations in the proportions of 35S-labelled high-affinity heparan sulphate chains in skin (10%) or brain (24%) between 4 and 22 months of age.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492320      PMCID: PMC1136251          DOI: 10.1042/bj3120245

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  The anticoagulant effect of heparan sulfate and dermatan sulfate.

Authors:  A N Teien; U Abildgaard; M Höök
Journal:  Thromb Res       Date:  1976-06       Impact factor: 3.944

2.  Mast cell heterogeneity: effects of neuroenteric peptides on histamine release.

Authors:  F Shanahan; J A Denburg; J Fox; J Bienenstock; D Befus
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

3.  A proteoglycan form of heparin and its degradation to single-chain molecules.

Authors:  H C Robinson; A A Horner; M Höök; S Ogren; U Lindahl
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

4.  Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells.

Authors:  J A Marcum; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

5.  Native heparin from rat peritoneal mast cells.

Authors:  R W Yurt; R W Leid; K F Austen
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

6.  Asymmetric distribution of sites with high affinity for antithrombin III in rat skin heparin proteoglycans.

Authors:  A A Horner; E Young
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

7.  In vivo behavior of human radioiodinated antithrombin III: distribution among three physiologic pools.

Authors:  T H Carlson; T L Simon; A C Atencio
Journal:  Blood       Date:  1985-07       Impact factor: 22.113

8.  Pathway-specific regulation of the synthesis of anticoagulantly active heparan sulfate.

Authors:  N W Shworak; M Shirakawa; S Colliec-Jouault; J Liu; R C Mulligan; L K Birinyi; R D Rosenberg
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

9.  Mortality and growth characteristics of rat strains commonly used in aging research.

Authors:  E J Masoro
Journal:  Exp Aging Res       Date:  1980-06       Impact factor: 1.645

10.  Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells.

Authors:  K G Jacobsson; J Riesenfeld; U Lindahl
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.